Ads
related to: vertex pharmaceuticals- Our Company
Learn about our mission and
the values that drive us.
- Contact Us
Find all the ways to reach us
for the information you need.
- Our Company
Search results
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool via Yahoo Finance· 7 days agoCasgevy was developed in a partnership with Vertex Pharmaceuticals, which seems to be valuable for...
Is Bluebird Bio Stock a Buy?
Motley Fool via Yahoo Finance· 5 days agoCasgevy, another gene-editing treatment for SCD and TDT, earned approval recently. The team of Vertex Pharmaceuticals and CRISPR Therapeutics developed...
How Gene Editing Therapies Could Go Beyond Rare Diseases
Forbes· 5 days agoEarlier this year, a group of scientists in the Netherlands used the gene editing tool CRISPR to...
Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
Investor's Business Daily· 5 days agoThe biotech company showed 68% earnings growth last quarter. Sales gains came in at 21%. Halozyme...
Circular RNA: Vaccines, therapeutics and biomarkers could be revolutionised
Pharmaceutical Technology via Yahoo Finance· 6 days agoCircRNA is still in very early days of development, but it is expected to trialled in vaccines,...
'Hope is not naïve': At Notre Dame commencement, class of 2024 grads celebrate connection
South Bend Tribune· 1 day agoNot to mention that Tasende, an economics and political science major who plans to work for a Boston...
Dell Technologies' market cap exceeds $100B for the first time - Boston Business Journal
The Business Journals· 6 days agoThe market value of Dell Technologies crossed the $100 billion threshold for the first time while...
Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
Investor's Business Daily· 5 days agoIBD's unique RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoU.S. FDA clears Investigational New Drug application for THB335 Phase 1 SAD/MAD clinical trial initiated and subject screening underway, with results expected during 1H’25 Strengthened leadership team with the appointment of Christopher J.
Ads
related to: vertex pharmaceuticals
